Results for tag: "Occlusive Coronary Artery Disease Drug"

Occlusive Coronary Artery Disease (CAD) is a condition in which the coronary arteries become narrowed or blocked, reducing the flow of oxygen-rich blood to the heart. Cardiovascular drugs are used to treat CAD and its associated symptoms. These drugs include antiplatelet agents, anticoagulants, beta-blockers, calcium channel blockers, and statins. Antiplatelet agents are used to reduce the risk of blood clots, while anticoagulants are used to prevent the formation of clots. Beta-blockers are used to reduce the workload on the heart, while calcium channel blockers are used to reduce the force of contraction of the heart muscle. Statins are used to reduce the levels of cholesterol in the blood. Some of the major companies in the Occlusive Coronary Artery Disease Drug market include Pfizer, Merck & Co., Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, and Boehringer Ingelheim. Show Less Read more